Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

NativeMed vs Queen RX

NativeMed
Graded #191

Higher grade

vs+0.5
Queen RX
Graded #212

Lower grade

The verdict

NativeMed takes it — 66.5/100 to 66/100, but only just.

NativeMed grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. NativeMed, LLC (nativemed.net) is a Miami, FL-based cash-pay telehealth provider offering compounded semaglutide at promotional $149/mo (regular $299) and compounded tirzepatide at promotional $183/mo… Queen RX is close behind and may still be the better fit — see the factor split below.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueQueen RX +2
74
76
Dose & formulationNativeMed +7
64
57
Clinical oversightNativeMed +5
74
69
Labs & monitoringEven
53
53
FulfillmentQueen RX +8
67
75
Contract termsQueen RX +6
55
61
NativeMed · left barQueen RX · right bar

The numbers

MetricNativeMedQueen RX
WeighScore66.5/10066/100
GradeCC
Scorecard rank#191#212
Semaglutide$149/mo (promotional rate, compounded)$100/mo (quarterly plan, compounded)
Tirzepatide$183/mo (promotional rate, compounded)Not disclosed
CoverageCoverage not published45 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
NativeMed

Graded #191 · C

Strengths

  • LegitScript Certified (verifiable in the footer)
  • Promotional pricing shown publicly: $149/mo semaglutide, $183/mo tirzepatide
  • Online questionnaire intake, with a live visit added when state law requires it

Where it loses points

  • Pharmacy partners aren't named — described only as 'USA-based' or 'accredited' pharmacies
  • States served aren't listed publicly
  • Prices are promotional — confirm whether they hold past month one or rise to the $299/$399 regular rate
Queen RX

Graded #212 · C

Strengths

  • $299/quarter (~$100/mo) — among the lowest GLP-1 pricing in the dataset
  • Three GLP-1 options: semaglutide, tirzepatide, and liraglutide
  • 45-state coverage

Where it loses points

  • No LegitScript or PCAB accreditation
  • No legal entity name or address disclosed
  • No named pharmacy partners
  • Not available in KS, LA, MS, NM, WV

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard